Cargando…
Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
OBJECTIVES: Venous sinus thrombosis (VST) after vaccination with the mRNA-based vaccine produced by Pfizer is comparatively rare and usually occurs after the first dose. VST after the second dose has been reported in only few patients. CASE REPORT: The patient is a 33yo male who experienced an episo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651552/ https://www.ncbi.nlm.nih.gov/pubmed/34901793 http://dx.doi.org/10.1016/j.hest.2021.12.001 |
_version_ | 1784611421659594752 |
---|---|
author | Finsterer, Josef Nics, Sebastian |
author_facet | Finsterer, Josef Nics, Sebastian |
author_sort | Finsterer, Josef |
collection | PubMed |
description | OBJECTIVES: Venous sinus thrombosis (VST) after vaccination with the mRNA-based vaccine produced by Pfizer is comparatively rare and usually occurs after the first dose. VST after the second dose has been reported in only few patients. CASE REPORT: The patient is a 33yo male who experienced an episode of sudden onset focal, stabbing headache in the left temporal region for about 4 h. Three days later a similar episode occurred accompanied by a focal seizure. Twenty days before he had received the second dose of the Pfizer vaccine. Clinical exam was normal but MRI of the brain revealed a VST of the left transverse and sigmoid sinuses. Anticoagulation with low molecular weight heparin followed by dabigatran resulted in complete recovery. CONCLUSIONS: This case shows that also the second dose of the Pfizer vaccine can be followed by a VST. Currently, there are more arguments in favour of a causal relation between the vaccination and the VST than against it. |
format | Online Article Text |
id | pubmed-8651552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86515522021-12-08 Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine Finsterer, Josef Nics, Sebastian Brain Hemorrhages Case Report OBJECTIVES: Venous sinus thrombosis (VST) after vaccination with the mRNA-based vaccine produced by Pfizer is comparatively rare and usually occurs after the first dose. VST after the second dose has been reported in only few patients. CASE REPORT: The patient is a 33yo male who experienced an episode of sudden onset focal, stabbing headache in the left temporal region for about 4 h. Three days later a similar episode occurred accompanied by a focal seizure. Twenty days before he had received the second dose of the Pfizer vaccine. Clinical exam was normal but MRI of the brain revealed a VST of the left transverse and sigmoid sinuses. Anticoagulation with low molecular weight heparin followed by dabigatran resulted in complete recovery. CONCLUSIONS: This case shows that also the second dose of the Pfizer vaccine can be followed by a VST. Currently, there are more arguments in favour of a causal relation between the vaccination and the VST than against it. International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2022-03 2021-12-08 /pmc/articles/PMC8651552/ /pubmed/34901793 http://dx.doi.org/10.1016/j.hest.2021.12.001 Text en © 2021 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Report Finsterer, Josef Nics, Sebastian Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine |
title | Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine |
title_full | Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine |
title_fullStr | Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine |
title_full_unstemmed | Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine |
title_short | Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine |
title_sort | venous sinus thrombosis after the second jab of an mrna-based sars-cov-2 vaccine |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651552/ https://www.ncbi.nlm.nih.gov/pubmed/34901793 http://dx.doi.org/10.1016/j.hest.2021.12.001 |
work_keys_str_mv | AT finstererjosef venoussinusthrombosisafterthesecondjabofanmrnabasedsarscov2vaccine AT nicssebastian venoussinusthrombosisafterthesecondjabofanmrnabasedsarscov2vaccine |